• Mia product against a white background floating in someone's hand

    Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.

    KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ — Mel-Mont Medical, a boutique medical device and technology company dedicated to improving women’s …Continue Reading

    Learn More
  • Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests

    C. E. Aranda Flores , G. Gomez Gutierrez, J. M. Ortiz Leon, D. Cruz Rodriguez and S. W. Sørbye Abstract …Continue Reading

    Learn More
  • woman smiling and holding Mia box against a floral background

    Mel-Mont Medical, LLC announces the development of Mía by XytoTest®

    Mel-Mont Medical, LLC announces the development of Mía by XytoTest® MEXICO CITY, May 17, 2017 /PRNewswire/ — Mía by XytoTest® is a preventive …Continue Reading

    Learn More